Skip to main content

and
  1. Article

    Open Access

    PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma

    Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumours, warranting novel treatments. Here, we examined the therapeutic efficacy of inhibiting p21 activated kinase 4 (PAK4) in OSCC and ...

    Danki Takatsuka, Hidetake Tachinami, Nihei Suzuki, Manabu Yamazaki in Scientific Reports (2024)